by Mejbel Alazemi | Nov 5, 2026 | Commentary, Featured, Grand Round Summaries, Patient Advocacy
Emergency medicine is defined by uncertainty. But when uncertainty becomes a reflex to test, test, and test again, we may be doing more harm than good with low value testing. I want to tell you about two emergency physicians. Same hospital. Same patient: a...
by Naman Arora | Oct 1, 2026 | Critical Care, Featured, Grand Round Summaries, Infectious Disease, Resuscitation
Sepsis resuscitation has evolved considerably over the past two decades, moving away from rigid protocols toward more individualized care. Yet many familiar targets remain: 30 mL/kg of fluid, a MAP of 65, and lactate clearance. But not every patient benefits from more...
by Caroline Gregory | Sep 30, 2026 | Journal Club, Thrombosis
Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism (Therapy) Castellucci LA, et al. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703. Editorial: Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous...
by Thariq Badiudeen, Rajiv Thavanathan | Jul 16, 2026 | Cardiology, Critical Care, Featured, Grand Round Summaries, Resuscitation, Ultrasound
Valvular heart disease is everywhere in emergency medicine, but it is sneaky. We see the older patient with recurrent dyspnea whose chest radiograph is unremarkable and BNP is only mildly elevated. We see the patient in shock whose physiology never quite fits sepsis....
by Sam Wilson, Venkatesh Thiruganasambandamoorthy | Jun 1, 2026 | Critical Care, Journal Club, Resuscitation
Personalized Hemodynamic Resuscitation Targeting Capillary Refill Time in Early Septic Shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial. Hernandez G, ANDROMEDA-SHOCK-2 Investigators for the ANDROMEDA Research Network JAMA. 2025 Oct 29:e2520402. doi:...
